Giant urticaria and persistent neutralizing antibodies after the first natalizumab infusion.
Cohen
M
M
Service de Neurologie, Hopital Pasteur, CHU de Nice, 06002 Nice cedex, France.
Rocher
F
F
Vivinus
S
S
Thomas
P
P
Lebrun
C
C
D000328:Adult; D000799:Angioedema / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D057134:Antibodies, Neutralizing / Q000097:blood*; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000097:blood / Q000628:therapy*; D000069442:Natalizumab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D057134:Antibodies, Neutralizing; D006633:Histamine Antagonists; D000069442:Natalizumab